Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will have access to new and expanded medicines ...

Soligenix (SNGX) announced the formation of a European Medical Advisory Board to provide additional medical/clinical strategic guidance to the ...

In a significant step towards expanding its academic mission, Vision Radiology proudly announces its strategic alliance ...

DeBogy Molecular, Inc, a privately held biotech that specializes in antimicrobial surface modification, announced their Board of Directors has approved a new capital raise to support the Company's ...